EU5 Cytomegalovirus (CMV) Infection Epidemiology Insights 2017-2023 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Cytomegalovirus (CMV) Infection - Epidemiology Insights - 2023 - EU5" report to their offering.

This report provides an overview of the disease and the historical and forecasted epidemiological data for the Cytomegalovirus (CMV) Infection in EU5 (France, Germany, Italy, Spain and United Kingdom) for 2013 - 2023.

According to experts, the total number of Diagnosed Cytomegalovirus (CMV) infection cases in France is expected to increase at a CAGR of 0.06% to 20,871 cases by 2023.

In case of Germany it is expected to increase at a CAGR of 0.067% to 21,619 cases by 2023.

In United Kingdom, the total number of Diagnosed Cytomegalovirus (CMV) infection cases is expected to increase at a CAGR of 0.061% to 14,417 cases by 2023 and in Spain is expected to increase at a CAGR of 0.029% to 12,810 cases in 2023.

For Italy, it is expected to increase at a CAGR of 0.031% to 13,358 cases in 2023. CMV infection is most prevalent in Italy and least prevalent in Spain of the EU5.

Key Topics Covered:

  1. Cytomegalovirus Infections
  2. Disease Overview
  3. Symptoms of cytomegalovirus (CMV) Infection
  4. Etiology
  5. Risk Factors
  6. Pathogenesis of human cytomegalovirus
  7. Pathophysiology of cytomegalovirus infection
  8. Diagnosis
  9. Epidemiology and Patient Population
  10. Total CMV Prevalent, Diagnosed and Treatable Cases: Historical Data (2013-2015)
  11. Total CMV Prevalent, Diagnosed and Treatable Cases: Forecasted Data (2016-2023)
  12. CMV Patients among Transplants: Historical Data (2013-2015)
  13. CMV Patients among Transplants: Forecasted Data (2016-2023)
  14. Infants Patients at High Risk of CMV: Historical Data (2013-2015)
  15. Infants Patients at High Risk of CMV: Forecasted Data (2016-2023)
  16. HIV Patients at High Risk of CMV: Historical Data (2013-2015)
  17. HIV Patients at High Risk of CMV: Forecasted Data (2016-2023)
  18. Unmet Medical Needs
  19. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/jxndmk/cytomegalovirus

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs